NUT midline carcinoma of the head and neck: current perspectives.

Napolitano, M; Venturelli, M; Molinaro, E; Toss, A

Napolitano, M; Venturelli, M; Molinaro, E; Toss, A.

Afiliação

Napolitano M; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
Venturelli M; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
Molinaro E; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
Toss A; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.

Onco Targets Ther ; 12: 3235-3244, 2019.

Article em En | MEDLINE | ID: mdl-31118674

Palavras-chave

BET inhibitors; BRD4-NUT; NUT midline carcinoma; head and neck; histone deacetylase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google